Нерцелуларни рак плућа са метастазама у мозгу и АЛК циљаном терапијом

Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases had a poor prognosis, with a median survival time of 7 months. But tumor-specific mutations have triggered a wave of ..

Иресса Троцаине у лечењу карцинома плућа са малим ћелијама мутираног ЕГФР-ом

Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for effective targeted drugs and ..

Генетско тестирање води лечење АЛК позитивног карцинома плућа

Cancer genetic testingCancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for effective targeted drugs and c..

ЕДГЕ неинвазивна туморска радиохирургија за рак плућа

Cancer related deaths in United StatesThe American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer death rate in the United States has fallen by 22% from its peak in 1991 to ..

Вишеструко генетско тестирање тумора рака плућа

A study published online in the Journal of the American Medical Association on May 21st showed that multiple genetic tests of lung cancer tumors can help select genetic abnormalities for targeted therapy. Compared with patients w..

Стереотактичка радиотерапија карцинома плућа која се не може хируршки уклонити

Stereotactic body radiation therapyStereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR). Since its application in the mid-1990s, SBRT has distinguished itself in the radical treatmen..

Упутство за употребу Опдиво -ниволумаба за пацијенте са немићелијским карциномом плућа

Opdivo has been listed in the United States for the treatment of lung cancer. Many cancer patients cannot go abroad for treatment for various reasons. Consult Opdivo on how to use it and hope to be able to buy medicine from abroad..

Лек против рака Опдиво постаје први ПД-1 лек који лечи рак плућа

On January 13, 2015, Huanyu Dakang Medical News pharmaceutical giant Squibb Company ushered in a good start in 2015. The anti-cancer immunotherapy drug nivolumab developed by the company was approved last month under the trade na..

Студија случаја рака плућа и клиничко испитивање

1. Diagnosis and first treatment of lung cancerPatient Lu was diagnosed with lung adenocarcinoma and lymph node metastasis on August 26, 2005. A left lower lobectomy was performed on September 22, 2005. Carboplatin combined with ..

Класификација

Класификација аденокарцинома плућа и хируршка перспектива рака плућа

1. Individualized scope of lung parenchymal resection Since the 1960s, regardless of tumor size, anatomical lobectomy has become the standard for surgical treatment of non-small cell lung cancer . However, the lung function o..